Literature DB >> 12750379

An artificially designed pore-forming protein with anti-tumor effects.

H Michael Ellerby1, Sannamu Lee, Lisa M Ellerby, Sylvia Chen, Taira Kiyota, Gabriel del Rio, Gohsuke Sugihara, Yan Sun, Dale E Bredesen, Wadih Arap, Renata Pasqualini.   

Abstract

Protein engineering is an emerging area that has expanded our understanding of protein folding and laid the groundwork for the creation of unprecedented structures with unique functions. We previously designed the first native-like pore-forming protein, small globular protein (SGP). We show here that this artificially engineered protein has membrane-disrupting properties and anti-tumor activity in several cancer animal models. We propose and validate a mechanism for the selectivity of SGP toward cell membranes in tumors. SGP is the prototype for a new class of artificial proteins designed for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750379     DOI: 10.1074/jbc.M300474200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  In vivo potential of recombinant granulysin against human tumors.

Authors:  Sameer Al-Wasaby; Diego de Miguel; Adriana Aporta; Javier Naval; Blanca Conde; Luis Martínez-Lostao; Alberto Anel
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

Review 2.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

3.  Identification of a novel lytic peptide for the treatment of solid tumours.

Authors:  Rolf Bjerkvig; Lars Prestegarden; Claudia Szczepanski; Olav Tenstad; Anne Baumann; Aurora Martinez; Reidar Myklebust
Journal:  Genes Cancer       Date:  2014-05

4.  Systematic Design and Validation of Ion Channel Stabilization of Amphipathic α-Helical Peptides Incorporating Tryptophan Residues.

Authors:  Keita Shigedomi; Satoshi Osada; Masoud Jelokhani-Niaraki; Hiroaki Kodama
Journal:  ACS Omega       Date:  2020-12-29

Review 5.  From antimicrobial to anticancer peptides. A review.

Authors:  Diana Gaspar; A Salomé Veiga; Miguel A R B Castanho
Journal:  Front Microbiol       Date:  2013-10-01       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.